19 September 2025
Merck's ENFLONSIA™ Recommended by EU CHMP for RSV Prevention in Infants
ENFLONSIA™ awaits EU approval for infant RSV prevention, offering a single-dose option for all weights. Backed by Phase 2b/3 and Phase 3 trials, decision expected by year-end.
